The importance of AI literacy in life sciences
pharmaphorum
JANUARY 13, 2023
The promise and value of artificial intelligence (AI) in life sciences are somewhat obscured by the over-generalisation of this technology.
pharmaphorum
JANUARY 13, 2023
The promise and value of artificial intelligence (AI) in life sciences are somewhat obscured by the over-generalisation of this technology.
Fierce Pharma
JANUARY 9, 2023
JPM23, Day 1: BMS touts new launches as patent cliff looms; Regeneron's Eylea sales disappoint. esagonowsky. Mon, 01/09/2023 - 09:55
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Impetus Digital
JANUARY 13, 2023
It is the time of year when everyone predicts what the next 12 months will hold. At Impetus Digital, we get a first-hand look into evolving industry trends daily from our clients and their advisors, putting us in a unique position to make these predictions.
PharmExec
JANUARY 11, 2023
As new forms of cell and gene therapies continue to be developed, life sciences companies and payers need to find alternative ways to pay for these expensive treatments. Value-based contracts, though slow to gain traction so far, may provide the solution these groups are looking for.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.
pharmaphorum
JANUARY 12, 2023
Bayer has signed an agreement with Google aimed at using high-level processing power to handle quantum chemistry calculations used to predict the chemical and physical properties of drug molecules at the atomic scale.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaVoice
JANUARY 12, 2023
Merck, Bristol Myers Squibb and others are taking small R&D steps in space that could lead to giant leaps for patients
PharmExec
JANUARY 11, 2023
The steps companies can take now to better protect themselves and their data.
pharmaphorum
JANUARY 11, 2023
Over the past few decades, data generation has veritably exploded. However, the ‘Big Data paradigm’ is not so much concerned with the volume of that data, but how businesses and, indeed, industries can derive meaningful insights from what has become a glut of information.
Fierce Pharma
JANUARY 9, 2023
JPM23: Moderna reaped $18.4B in COVID vaccine sales last year, projects at least $5B in 2023. kdunleavy. Mon, 01/09/2023 - 10:34
Clear Pivot
JANUARY 13, 2023
Your website is one of the most important tools you have to communicate what your senior living community is all about. And what better way to showcase that than involving your residents?
Legacy MEDSearch
JANUARY 13, 2023
Hip Innovation Technology , LLC (HIT), a medical device company developing innovative orthopaedic device solutions to advance the quality of life and quality of care for patients, is pleased to announce the first U.S.
pharmaphorum
JANUARY 8, 2023
Before the main event at JP Morgan 2023 even kicks off, we’re checking out the Sachs Associates Neuroscience Innovation Forum on Sunday.
Fierce Pharma
JANUARY 10, 2023
JPM23: Novavax hopes end of COVID emergency—and open vaccine market—will help it grow market share. aarmstrong. Tue, 01/10/2023 - 10:24
PharmaVoice
JANUARY 11, 2023
The chief strategy officer of Form Bio is harnessing the new company’s computing power and bioinformatics to spur a genomic revolution
PharmaTech
JANUARY 11, 2023
We have proposed a comprehensive capping index parameter which is a ratio of compact anisotropic index to material anisotropic index. This study will help to design or select right tooling for successful tablet manufacturing.
pharmaphorum
JANUARY 10, 2023
Astellas has licensed rights to a drug developed by Selecta Biosciences that could make more patients eligible for treatment with its gene therapy for inherited neuromuscular disorder Pompe disease.
Fierce Pharma
JANUARY 10, 2023
JPM23, Day 2: Takeda readies for dengue vaccine launch; Merck touts recent deals. kdunleavy. Tue, 01/10/2023 - 06:24
PharmExec
JANUARY 11, 2023
What a changing economy and related trends could mean for 2023.
PharmaVoice
JANUARY 13, 2023
Execs at JPM sound off on moves companies can make to survive the challenging market conditions
pharmaphorum
JANUARY 9, 2023
Novartis’ programme providing free access to its spinal muscular atrophy (SMA) gene therapy Zolgensma is being scaled back to a dozen countries worldwide, according to the company.
Fierce Pharma
JANUARY 9, 2023
JPM23: Chiesi gets jump-start on JPM buzz with $1.48B Amyrt buyout. esagonowsky. Mon, 01/09/2023 - 08:14
Legacy MEDSearch
JANUARY 10, 2023
VERO Biotech Inc., a commercial-stage healthcare business dedicated to neonatal intensive care and the acute care hospital community, announced FDA approval of the newest generation of its tankless inhaled nitric oxide (iNO) delivery system. .
PharmaVoice
JANUARY 9, 2023
How the IRLAB Therapeutics CEO is guiding the company in its development of potentially groundbreaking Parkinson’s disease treatments
pharmaphorum
JANUARY 9, 2023
We’re preparing to start JP Morgan week with a busy day Monday, with day 1 of the Informa Biotech Showcase, including a dedicated mini-event on Cell and Gene Therapy in the morning.
Fierce Pharma
JANUARY 11, 2023
AstraZeneca's first-in-class rescue inhaler Airsupra wins FDA nod—but only for adult use. esagonowsky. Wed, 01/11/2023 - 09:03
PharmExec
JANUARY 9, 2023
"The customer is always right" — a commitment to omnichannel marketing is a commitment to serving the customer. David Laros of Beghou Consulting offers up this tersely written playbook on the topic.
Pharma Pathway
JANUARY 7, 2023
Sun Pharma- Walk-In Drive for QC/ Production On 8th Jan’ 2023 & Send Resumes for Engineering/ QA/ Warehouse. Job Description. Walk-In Interview for Sun Pharma, Paonta Sahib On 8th Jan’ 2023. We are Hiring @ Sun Pharma, Paonta Sahib. Department: QC/ Production.
pharmaphorum
JANUARY 10, 2023
mRNA specialist BioNTech has driven its partnership with UK artificial intelligence InstaDeep into top gear, agreeing to buy the company outright in a cash and equity deal that values it at up to £562 million ($683 million).
Fierce Pharma
JANUARY 11, 2023
Lilly, Biogen and more gear up for blockbuster launches in 2023: report. kdunleavy. Wed, 01/11/2023 - 10:19
Legacy MEDSearch
JANUARY 9, 2023
Lydus Medical is pleased to announce that the Vesseal has received FDA clearance 510(k). The Vesseal is a microvascular anastomosis suture deployment system, for standardized omni-vessel anastomoses, enabling simple, fast, safe, and effective procedures.
PharmaTech
JANUARY 10, 2023
Public relations agencies dissect pharmaceutical trends: Brandwidth Solutions, Orientation Marketing and White Matter Communications.
pharmaphorum
JANUARY 13, 2023
The ‘big three’ insulin producers Novo Nordisk, Eli Lilly, and Sanofi are being sued by the state of California for allegedly working together to set artificially inflated prices for their products.
Fierce Pharma
JANUARY 9, 2023
JPM23: Regeneron reports disappointing sales of powerhouse Eylea, says it's a 'blip'. kdunleavy. Mon, 01/09/2023 - 14:21
Let's personalize your content